NCT00664560View on ClinicalTrials.gov

Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis

PHASE3CompletedINTERVENTIONAL
Enrollment

614

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
Osteoarthritis
Interventions
DRUG

PN 400 (VIMOVO)

500 mg naproxen/20 mg esomeprazole bid

DRUG

celebrex

200 mg celecoxib qd

DRUG

Placebo

sugar pill bid

DRUG

Rescue Antacid

Antacid Tablets

Trial Locations (1)

27517

POZEN, Chapel Hill

Sponsors

Lead Sponsor

POZEN
All Listed Sponsors
lead

POZEN

INDUSTRY

NCT00664560 - Efficacy Study of PN400 (VIMOVO) Twice Daily and Celebrex Once Daily in Patients With Osteoarthritis | Biotech Hunter | Biotech Hunter